<DOC>
	<DOCNO>NCT02342899</DOCNO>
	<brief_summary>Obesity escalate issue , accompany increase referral patient obesity-related respiratory failure . Currently , patient electively admit hospital initiation non-invasive ventilation ( NIV ) , unknown whether outpatient initiation effective inpatient set-up . The investigator hypothesise outpatient set use auto-titrating NIV device cost effective nurse-led inpatient titration set-up . The investigator undertake multi-national , multi-centre randomise controlled trial . Subjects randomise receive usual inpatient set-up , include nurse-led initiation NIV outpatient set-up automate NIV device . Subjects stratify accord trial site , gender previous use NIV continuous positive airway pressure . Assuming 10 % drop rate , total sample 82 patient require . Cost effectiveness evaluate use standard treatment cost health service utilisation use health relate quality life measure ( SRI EQ5D ) . Change severe respiratory insufficiency ( SRI ) questionnaire base analysis covariance ( ANCOVA ) adjust baseline measurement two arm patient .</brief_summary>
	<brief_title>Cost Effectiveness Outpatient Set-up Automated NIV Obese Patients With Chronic Respiratory Failure</brief_title>
	<detailed_description>There increase patient hypercapnic respiratory failure consequence obesity . The current treatment option patient obesity related respiratory failure non-invasive ventilation ( NIV ) . This show reduce partial pressure arterial carbon dioxide ( PaCO2 ) improve symptoms dyspnea ( breathlessness ) enhance quality life . NIV also show increase physical activity ( use actigraphy ) associate weight reduction three month initiation . Currently , length inpatient stay NIV set 4.5 6 day . As yet unknown whether patient set onto NIV effectively outpatient basis use AE-AVAPS ( Automatic Expiratory Positive Airway Pressure - Average Volume Assured Pressure Support ) algorithm compare usual practice inpatient titration specialist respiratory nurse . Furthermore , cost effectiveness outpatient initiation v inpatient initiation unknown group patient . This first trial ass cost effectiveness set .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Hypoventilation</mesh_term>
	<mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
	<criteria>Obese patient chronic respiratory failure Age &gt; 18 year Chronic hypercapnia ( daytime PaCO2 &gt; 6.0kPa ) Evidence sleep disorder breathe overnight oximetry study ( 4 % oxygen desaturation index &gt; 10events per hour and/or &gt; 30 % total analysis time SpO2 &lt; 90 % ) Patients recent acute episode require noninvasive ventilation need minimum 2 week stability prior enrolment trial ( NIV requirement 2 week pH ( Inverse logarithm hydrogen ion concentration ) ≥ 7.3 ) BMI ≥ 35kg/m2 FEV1/FVC ( Forced Expiratory Volume 1 second/Forced Vital Capacity ) &gt; 70 % Persistent hypercapnic respiratory acidosis define pH &lt; 7.30 Severe hypoxic and/or hypercapnic respiratory failure define PaO2 ( Partial Pressure Oxygen ) &lt; 7.0kPa and/or PaCO2 &gt; 9kPa ( kilopascal ) Failure tolerate NIV initiation require treat acute decompensation Hypercapnic respiratory failure require intubation within last 28 day Hypercapnic respiratory failure secondary identifiable cause obesity Acute coronary syndrome unstable angina Cognitive impairment would prevent informed consent trial and/or inability comply protocol Psychiatric disease necessitate antipsychotic medication , ongoing treatment drug alcohol addiction , person fix abode postdischarge Patients undergoing renal replacement therapy Patients coexistent cancer prognosis likely less 12months Critical peripheral vascular disease await revascularisation procedure ( claudication distance &lt; 100 metre ) Stroke hemiparesis Age &lt; 18 year Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>